Check out our most popular compounded medications! Get Started
Buprenorphine 4 mg Rapid Dissolve Tablet is a compounded medication designed to treat a range of conditions including opioid dependence, chronic pain, anxiety, depression, and insomnia. Its unique formulation allows it to dissolve quickly in the mouth, offering swift relief to patients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the Buprenorphine 4 mg Rapid Dissolve Tablet, a compounded formulation designed to treat a range of conditions. This medication is primarily used for the treatment of opioid dependence, chronic pain, severe pain, postoperative pain, and cancer pain. The unique formulation of this medication allows it to dissolve quickly in the mouth, facilitating rapid absorption and providing swift relief.
Buprenorphine is an opioid agonist-antagonist, which means it binds to opioid receptors in the brain, blocking the effects of other opioids while simultaneously providing pain relief. It works by reducing pain intensity and enhancing the quality of life for patients.
For those considering this formulation, it is crucial to understand that Buprenorphine 4 mg Rapid Dissolve Tablet should only be used under the guidance of a healthcare provider. It is essential to adhere to all instructions and take the medication as prescribed. Potential side effects of this medication may include nausea, vomiting, constipation, dizziness, and drowsiness. It is important to be aware of these potential side effects and to discuss any concerns with your healthcare provider.
If you have any questions about Buprenorphine 4 mg Rapid Dissolve Tablet or any other medication, please do not hesitate to contact us at Bayview Pharmacy.
This compounded formulation of Buprenorphine 4 mg Rapid Dissolve Tablet is specifically designed for the management of various types of pain, including chronic pain, severe pain, postoperative pain, and cancer pain. It is also indicated for the treatment of opioid dependence. However, it is crucial to understand that this formulation is not recommended for the treatment of acute pain.
Patients using this medication should be closely monitored for any signs of misuse or abuse. Buprenorphine, the active ingredient in this formulation, has been linked with a risk of respiratory depression, particularly when used in conjunction with other central nervous system (CNS) depressants. Therefore, patients are strongly advised to abstain from alcohol and other CNS depressants while on this medication.
Additionally, patients should be monitored for signs of withdrawal, as sudden discontinuation of buprenorphine can lead to withdrawal symptoms. It is essential for patients to take this medication exactly as prescribed by their healthcare provider. They should not increase the dose without first consulting with their healthcare provider.
If you have any questions or concerns about this formulation or its use, please do not hesitate to reach out for further information. It is our goal to provide comprehensive and accurate information to ensure the safe and appropriate use of this medication.
Buprenorphine 4 mg Rapid Dissolve Tablet is a potent opioid medication primarily used in the management of opioid dependence, chronic pain, severe pain, postoperative pain, and cancer pain. This medication functions by binding to the opioid receptors in the brain, which helps in reducing the craving for opioids and effectively blocking the effects of other opioids. The unique rapid dissolve tablet form of buprenorphine facilitates faster absorption into the bloodstream, thereby providing quicker relief from pain and opioid withdrawal symptoms.
It is crucial to understand that buprenorphine is a partial opioid agonist. This means it has a lower potential for abuse and addiction compared to full opioid agonists. This characteristic makes it a safer option for long-term management of chronic pain and opioid dependence.
Buprenorphine 4 mg Rapid Dissolve Tablet should be taken strictly as prescribed by your healthcare provider. It is essential to adhere to the directions provided on the label and take the medication exactly as prescribed. Taking more or less than the prescribed dose can lead to undesirable effects. If you have any queries or concerns about how to take this medication, it is recommended to consult with your healthcare provider or pharmacist.
This compounded formulation of Buprenorphine 4 mg Rapid Dissolve Tablet is a versatile medication that can be used to treat a variety of conditions. This formulation is also beneficial in managing withdrawal symptoms from other opioids, such as heroin or oxycodone.
However, it is crucial to understand that this formulation is not intended for the treatment of acute pain or for short-term use. It is also not recommended to be used in conjunction with other opioids, as this can significantly increase the risk of overdose and other serious side effects.
Patients should be aware that this formulation may cause drowsiness. Therefore, it is advised to exercise caution when operating machinery or driving. It is always important to use this medication under the supervision of a healthcare professional and to follow the prescribed dosage to ensure safety and effectiveness.
If you have any questions or concerns about the use of this formulation, please do not hesitate to reach out for further information. It is our priority to ensure that you are fully informed about your medication and its potential effects.
Buprenorphine 4 mg Rapid Dissolve Tablet is a compounded formulation of the medication Buprenorphine. It is designed to dissolve quickly in the mouth for fast absorption into the bloodstream.
Buprenorphine is primarily used in the treatment of opioid addiction. It helps to prevent withdrawal symptoms caused by stopping other opioids.
This medication should be taken as directed by your healthcare provider. It is typically placed under the tongue to dissolve. It should not be swallowed as a whole tablet.
Common side effects may include dizziness, drowsiness, blurred vision, and feelings of extreme happiness or sadness. If any of these side effects persist or worsen, contact your healthcare provider immediately.
Always inform your healthcare provider about all the medications you are currently taking, including prescription and non-prescription drugs, vitamins, and herbal supplements. Some medications may interact with Buprenorphine, affecting its effectiveness or causing side effects.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Alcohol can increase the nervous system side effects of Buprenorphine such as dizziness, drowsiness, and difficulty concentrating. It is best to avoid or limit the use of alcohol while being treated with Buprenorphine.
If you are pregnant or breastfeeding, consult your healthcare provider before taking Buprenorphine. This medication may have potential risks for an unborn baby or nursing infant.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include severe drowsiness, slow breathing, and loss of consciousness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 tablet under the tongue and let dissolve before swallowing. Do not chew.
